17 completed. 17 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 17 | Completed 17 |
| Phase 2 | 2 | Completed 2 |
Follow Kidney Failure: new trials by email Literature Review of Kidney Failure trials Research Report on Kidney Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring MB-102, MediBeacon Transdermal Glomerular Filtration Rate Measurement System (TGFR) - Kidney Diseases, Kidney Injury | Phase 3 | Completed | MediBeacon | 149 | 2023-03-20 | 2025-03-28 |
| A Bioequivalence and Efficacy Study of MB-102 (Relmapirazin) in Chinese Participants MB-102 DMID, MB-102 OMID, MediBeacon Transdermal Glomerular Filtration Rate Measurement System (TGFR) - Kidney Diseases, Kidney Injury | Phase 3 | Completed | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 121 | 2023-03-02 | 2024-01-02 |
| A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis ferric citrate - End Stage Renal Disease, Kidney Failure | Phase 3 | Completed | Keryx Biopharmaceuticals | 168 | 2012-08-01 | 2016-07-13 |
| Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME) cyclosporin + mycophenolate mofetil, everolimus + mycophenolate mofetil - Kidney Failure | Phase 3 | Completed | Centre Hospitalier Universitaire, Amiens | 88 | 2012-05-03 | 2026-06-12 |
| Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae Venous Window Needle Guide - End Stage Renal Disease, AV Fistula | Phase 2 / Phase 3 | Completed | Vital Access Corp. | 54 | 2011-12-01 | 2016-06-03 |
| A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis ferric citrate, ca acetate, sevelamer carbonate, placebo - Hyperphosphatemia, Kidney Failure | Phase 3 | Completed | Keryx Biopharmaceuticals | 441 | 2010-10-01 | 2014-12-10 |
| Donor Simvastatin Treatment in Organ Transplantation Simvastatin 80mg, Control Rx - Heart Failure, Respiratory Failure | Phase 2 / Phase 3 | Completed | Helsinki University Central Hospital | 84 | 2010-06-01 | 2017-09-19 |
| Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant epoetin beta (NeoRecormon ®) - Kidney Failure | Phase 3 | Completed | Centre Hospitalier Universitaire, Amiens | 108 | 2007-10-01 | 2016-04-28 |
| EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease) calcium acetate, placebo - Hyperphosphatemia, Kidney Failure | Phase 3 | Completed | Nabi Biopharmaceuticals | 110 | 2005-05-01 | 2008-01-08 |
| Study Evaluating Sirolimus in Kidney Transplant Recipients. Cyclosporine, Steroids, Rapamune (Sirolimus) - Kidney Failure, Graft vs Host Disease | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 150 | 2005-01-01 | 2008-03-14 |
| Iron Sucrose in Stage 3/4 Kidney Disease Iron sucrose - Kidney Failure, Anemia | Phase 3 | Completed | Melbourne Health | 120 | 2004-08-01 | 2015-05-05 |
| Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis Clopidogrel, Placebo - Kidney Failure, Hemodialysis Fistula Thrombosis | Phase 3 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 877 | 2003-01-07 | 2025-09-19 |
| Aggrenox Prevention of Access Stenosis Aggrenox, Placebo - Kidney Failure | Phase 3 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 649 | 2003-01-01 | 2017-09-19 |
| Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients Cyclosporin or tacrolimus - Graft Rejection, Kidney Failure | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 190 | 2002-01-01 | 2011-03-08 |
| Stenting in Renal Dysfunction Caused by Atherosclerotic Renal Artery Stenosis Renal artery stent - Renal Artery Obstruction, Kidney Failure | Phase 3 | Completed | UMC Utrecht | 140 | 2000-06-01 | 2006-04-27 |
| Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients cyclosporine A - Kidney Transplantation, Primary Prevention | Phase 3 | Completed | University Hospital, Rouen | 208 | 2000-04-01 | 2026-06-04 |
| A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects. epoetin alfa - Anemia, Kidney Failure | Phase 3 | Completed | Janssen-Ortho Inc., Canada | 172 | 1997-12-01 | 2011-02-01 |
Renal Insufficiency (17) · Hyperphosphatemia (3) · Kidney Failure, Chronic (3) · Anemia (2) · Kidney Diseases (2) · Arteriovenous Fistula (1) · Atherosclerosis (1) · Graft vs Host Disease (1) · Heart Failure (1) · Hypertension (1) · Hypertrophy, Left Ventricular (1) · Liver Failure (1) · Rejection, Psychology (1) · Renal Artery Obstruction (1) · Renal Insufficiency, Chronic (1)
Female Urogenital Diseases (17) · Female Urogenital Diseases and Pregnancy Complications (17) · Male Urogenital Diseases (17) · Urogenital Diseases (17) · Urologic Diseases (17) · Kidney Diseases (15) · Pathological Conditions, Signs and Symptoms (5) · Cardiovascular Diseases (4) · Pathologic Processes (4) · Chronic Disease (3) · Disease Attributes (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Phosphorus Metabolism Disorders (3) · Vascular Diseases (3)
Cyclosporine (4) · calcium acetate (2) · ferric citrate (2) · relmapirazin (2) · Aspirin (1) · Aspirin, Dipyridamole Drug Combination (1) · Clopidogrel (1) · Dipyridamole (1) · Epoetin Alfa (1) · Everolimus (1) · Ferric Oxide, Saccharated (1) · Mycophenolic Acid (1) · Sevelamer (1) · Simvastatin (1) · Sirolimus (1)
Centre Hospitalier Universitaire, Amiens (2) · Keryx Biopharmaceuticals (2) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · Wyeth is now a wholly owned subsidiary of Pfizer (2) · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (1) · Helsinki University Central Hospital (1) · Janssen-Ortho Inc., Canada (1) · MediBeacon (1) · Melbourne Health (1) · Nabi Biopharmaceuticals (1) · UMC Utrecht (1) · University Hospital, Rouen (1) · Vital Access Corp. (1)
United States (7) · France (3) · Puerto Rico (2) · Australia (1) · China (1) · Finland (1) · Israel (1) · Italy (1) · Netherlands (1)
Catherine Meyers, M.D. (2) · John W Kusek, Ph.D. (2) · Julia B Lewis, MD (2) · Dong Sun (1) · Jaap J. Beutler, MD.PhD (1) · Karl B Lemstrom, MD, PhD (1) · Lawrence P McMahon, MD (1) · Mark Crawford, BA (1) · Samuel Blumenthal, MD (1)
PMID 18477783, PMID 35224730, PMID 40576086, PMID 16253719, PMID 19414832, PMID 19458364, PMID 20642691, PMID 21324193, PMID 24833247, PMID 26239948, PMID 31352795, PMID 34298589, PMID 36791280
U01DK058982 (2)